Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

39.64 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents. ↗

January 03, 2024

Don't overlook HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

Why Harmony Biosciences Stock Got Slammed Today ↗

January 02, 2024

The commercial-stage company was dinged by a bearish new take from a researcher.

Via The Motley Fool

A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts ↗

January 02, 2024

Via Benzinga

2023 Year In Review ↗

January 02, 2024

The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.

Via Talk Markets

Topics Stocks

NASDAQ:HRMY is showing good growth, while it is not too expensive. ↗

December 18, 2023

HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) stands out as a growth opportunity that won't break the bank.

Via Chartmill

Harmony Biosciences's Earnings Outlook ↗

October 30, 2023

Via Benzinga

Analyst Ratings for Harmony Biosciences ↗

October 16, 2023

Via Benzinga

In the world of growth stocks, NASDAQ:HRMY shines as a value proposition. ↗

October 12, 2023

NASDAQ:HRMY, a growth stock which is not overvalued.

Via Chartmill

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

Via InvestorPlace

NASDAQ:HRMY, an undervalued stock with good fundamentals. ↗

December 13, 2023

When you look at HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On ↗

December 07, 2023

Although Russell 2000 stocks may operate in the lightweight category, these entities could potentially provide a knockout punch.

Via InvestorPlace

Looking for growth without the hefty price tag? Consider NASDAQ:HRMY. ↗

November 27, 2023

Investors seeking growth at a reasonable cost should explore HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY).

Via Chartmill

NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying. ↗

November 22, 2023

HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable. ↗

November 03, 2023

Investors should take note ofHARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), a growth stock that remains attractively priced.

Via Chartmill

Quick Look At Reports From ServiceNow, Chipotle, And Harmony ↗

November 02, 2023

ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.

Via Talk Markets

NASDAQ:HRMY is an undervalued gem with solid fundamentals. ↗

November 01, 2023

For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.

Via Chartmill

Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript ↗

October 31, 2023

HRMY earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results

October 31, 2023

From Harmony Biosciences

Via GlobeNewswire

Why Harmony Biosciences Stock Is Trading Higher Today ↗

October 16, 2023

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU

Via Benzinga

Nasdaq Down Over 1%; Wells Fargo Beats Expectations ↗

October 13, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 13, 2023

Via Benzinga

Stocks Mixed Amid Earnings, Consumer Sentiment Data ↗

October 13, 2023

Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.

Via Talk Markets

Why Shares of Harmony Bioscience Are Falling on Friday ↗

October 13, 2023

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

Via The Motley Fool

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

Crude Oil Rises Sharply; Citigroup Posts Upbeat Earnings ↗

October 13, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.05% to 33,615.27 while the NASDAQ fell 1.22% to 13,409.29. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today? ↗

October 13, 2023

Harmony Biosciences Holdings Inc (NASDAQ: HRMY) announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH).

Via Benzinga

New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies ↗

October 11, 2023

Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.

Via Benzinga

2 Magnificent Growth Stocks to Buy Right Now ↗

October 04, 2023

These two biotech stocks could be big winners for patient investors.

Via The Motley Fool

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.